Quick Answer
Design Therapeutics, Inc. reported Shares Outstanding of 60.40 million shares for fiscal year 2025.
Design Therapeutics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 60.40M | +6.4% |
| 2024 | 56.75M | +0.5% |
| 2023 | 56.47M | +1.0% |
| 2022 | 55.90M | +0.8% |
| 2021 | 55.44M | +247.4% |
| 2020 | 15.96M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 56.96M | +0.6% | +0.0% |
| June 30, 2025 | 56.95M | +0.6% | +0.3% |
| March 31, 2025 | 56.77M | +0.5% | +0.0% |
| December 31, 2024 | 56.75M | +0.5% | +0.2% |
| September 30, 2024 | 56.62M | +1.1% | +0.0% |
| June 30, 2024 | 56.62M | +1.1% | +0.2% |
| March 31, 2024 | 56.49M | +1.0% | +0.0% |
| December 31, 2023 | 56.47M | +1.0% | +0.8% |
- Design Therapeutics, Inc. showed an increase of +6.4% in Shares Outstanding compared to the prior fiscal year.
- Over the 2020–2025 period, Design Therapeutics, Inc.’s shares outstanding has grown by 278.5% (from 15.96 million shares to 60.40 million shares).
- The most recent figure is from Design Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 9, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: